Patient experiences with intensive combination-treatment strategies with glucocorticoids for early rheumatoid arthritis

Patient Education and Counseling

Volumn 98, Issue 3, 2015, Pages 384-390

  Meyfroidt, Sabrina ^a   Van der Elst, Kristien ^b,c   De Cock, Diederik ^a   Joly, Johan ^c   Westhovens, René ^a,c   Hulscher, Marlies ^d   Verschueren, Patrick ^a,c  

^a SKELETAL BIOLOGY AND ENGINEERING RESEARCH CENTER   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Early rheumatoid arthritis; Intensive combination treatment strategies; Patient perspective; Qualitative research

Indexed keywords

GLUCOCORTICOID; LEFLUNOMIDE; METHOTREXATE; SALAZOSULFAPYRIDINE; ANTIRHEUMATIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE DURATION; EARLY RHEUMATOID ARTHRITIS; FEMALE; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HUMAN; INTENSIVE COMBINATION TREATMENT STRATEGY; INTERNET; LONGITUDINAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; PERSONAL EXPERIENCE; PHENOMENOLOGY; QUALITATIVE RESEARCH; RANDOMIZED CONTROLLED TRIAL (TOPIC); REASSURANCE; RELATIVE; RHEUMATOID ARTHRITIS; SELF CARE; TRUST; ARTHRITIS, RHEUMATOID; CLINICAL PRACTICE; COMBINATION DRUG THERAPY; EARLY INTERVENTION; INTERVIEW; MIDDLE AGED; NETHERLANDS; PATIENT SATISFACTION; QUESTIONNAIRE; TREATMENT OUTCOME;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG THERAPY, COMBINATION; EARLY MEDICAL INTERVENTION; FEMALE; GLUCOCORTICOIDS; HUMANS; INTERVIEWS AS TOPIC; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NETHERLANDS; PATIENT SATISFACTION; PRACTICE PATTERNS, PHYSICIANS'; QUALITATIVE RESEARCH; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 84921469598     PISSN: 07383991     EISSN: 18735134     Source Type: Journal    
DOI: 10.1016/j.pec.2014.11.011     Document Type: Article

References (39)

1. National Institute for Health and Clinical Excellence The management of rheumatoid arthritis in adults (Clinical guideline 79) 2009, NICE, London, http://www.nice.org.uk/CG79.
2. Smolen J.S., Landewé R., Breedveld F.C., Buch M., Nurmester G., Dougedos M., et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis 2013, 10.1136/annrheumdis-2013-204573.
3. Singh J.A., Furst D.E., Bharat A., Curtis J.R., Kavanaugh A.F., Kremer J.M., et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease - modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res 2012, 64:625-639.
4. Verhoeven A., Bibo J., Boers M., Engel G., Van Der Linden S. Cost-effectiveness and cost-utility of combination therapy in early rheumatoid arthritis: randomized comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone. COBRA trial group. Combinatietherapie Bij Reumatoïde Artritis. Rheumatology 1998, 37:1102-1109.
5. Verschueren P., Esselens G., Westhovens R. Daily practice effectiveness of a step-down treatment in comparison with a tight step-up for early rheumatoid arthritis. Rheumatology 2008, 47:59-64.
6. Goekoop-Ruiterman Y., De Vries-Bouwstra J., Allaart C., Van Zeben D., Kerstens P., Hazes J., et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum 2005, 52:3381-3390.
7. Rantalaiho V., Kautiainen H., Korpela M., Puolakka K., Blåfield H., Ilva K., et al. Physicians' adherence to tight control treatment strategy and combination DMARD therapy are additively important for reaching remission and maintaining working ability in early rheumatoid arthritis: a subanalysis of the FIN-RACo trial. Ann Rheum Dis 2014, 73:788-790.
8. Yazdany J., Schmajuk G., Robbins M., Daikh D., Beall A., Yelin E., et al. Choosing wisely: the American College of Rheumatology's top 5 list of things physicians and patients should question. Arthritis Care Res 2013, 65:329-339.
9. Meyfroidt S., van Hulst L., De Cock D., Van der Elst K., Joly J., Westhovens R., et al. Factors influencing the prescription of intensive combination treatmentstrategies for early rheumatoid arthritis. Scand J Rheumatol 2014, 43:265-272.
10. Wensing M., Elwyn G. Improving the quality of health care: methods for incorporating patients' views in health care. Brit Med J 2003, 326:877.
11. Wensing M., Elwyn G. Research on patients' views in the evaluation and improvement of quality of care. Qual Saf Health Care 2002, 11:153-157.
12. Elwyn G., Edwards A., Mowle S., Wensing M., Wilkinson C., Kinnersley P., et al. Measuring the involvement of patients in shared decision-making: a systematic review of instruments. Patient Educ Couns 2001, 43:5-22.
13. Epstein R.M. Whole mind and shared mind in clinical decision-making. Patient Educ Couns 2013, 90:200-206.
14. Rathert C., Wyrwich M.D., Boren S.A. Patient-centered care and outcomes: a systematic review of the literature. Med Care Res Rev 2012, 10.1177/1077558712465774.
15. Lempp H., Hofmann D., Hatch S.L., Scott D.L. Patients' views about treatment with combination therapy for rheumatoid arthritis: a comparative qualitative study. BMC Musculoskelet Disord 2012, 13:200.
16. van Tuyl L.H., Plass A.M., Lems W.F., Voskuyl A.E., Kerstens P.J., Dijkmans B.A., et al. Discordant perspectives of rheumatologists and patients on COBRA combination therapy in rheumatoid arthritis. Rheumatology 2008, 47:1571-1576.
17. Scherman M.H., Dahlgren L.O., Löwhagen O. Refusing to be ill: a longitudinal study of patients' experiences of asthma/allergy. Disabil Rehabil 2002, 24:297-307.
18. Naithani S., Gulliford M., Morgan M. Patients' perceptions and experiences of 'continuity of care' in diabetes. Health Expect 2006, 9:118-129.
19. Kay E.A., Punchak S. Patient understanding of the causes and medical treatment of rheumatoid arthritis. Rheumatology 1988, 27:396-398.
20. Taylor B. Phenomenology: one way to understanding nursing practice. Int J Nurs Stud 1993, 30:171-179.
21. Verschueren P., De Cock D., Corluy L., Joos R., Langenaken C., Taelman V., et al. Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate to high dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial. Ann Rheum Dis 2014, 10.1136/annrheumdis-2014-205489.
22. Burkhart P.V., Sabaté E. Adherence to long-term therapies: evidence for action. J Nurs Scholarsh 2003, 35:207.
23. Dierckx de Casterlé B., Gastmans C., Bryon E., Denier Y. QUAGOL: a guide for qualitative data analysis. Int J Nurs Stud 2011, 49:360-371.
24. Morrison E., Crosbie D., Capell H. Attitude of rheumatoid arthritis patients to treatment with oral corticosteroids. Rheumatology 2003, 42:1247-1250.
25. Townsend A., Backman C.L., Adam P., Li L.C. A qualitative interview study: patient accounts of medication use in early rheumatoid arthritis from symptom onset to early postdiagnosis. Brit Med J 2013, 10.1136/bmjopen-2012-002164.
26. Goekoop-Ruiterman Y.P.M., de Vries-Bouwstra J.K., Allaart C.F., Kerstens P.J.S.M., Grillet B.A.M., de Jager M.H., et al. Patient preferences for treatment: report from a randomized comparison of treatment strategies in early rheumatoid arthritis (BeSt trial). Ann Rheum Dis 2007, 66:1227-1232.
27. Neame R., Hammond A., Deighton C. Need for information and for involvement in decision making among patients with rheumatoid arthritis: a questionnaire survey. Arthritis Care Res 2005, 53:249-255.
28. Arthur V., Clifford C. Rheumatology: the expectations and preferences of patients for their follow-up monitoring care: a qualitative study to determine the dimensions of patient satisfaction. J Clin Nurs 2004, 13:234-242.
29. van Eijk-Hustings Y., Ammerlaan J., Voorneveld-Nieuwenhuis H., Maat B., Veldhuizen C., Repping-Wuts H. Patients' needs and expectations with regard to rheumatology nursing care: results of 23 multicenter focus group interviews. Ann Rheum Dis 2013, 72:831-835.
30. Hammond A. The use of self-management strategies by people with rheumatoid arthritis. Clin Rehabil 1998, 12:81-87.
31. Arthritis care: comparison of physicians' and patient's views. Semin Arthritis Rheum 2000, 30:100-110.
32. Ernst E. Usage of complementary therapies in rheumatology: a systematic review. Clin Rheumatol 1998, 17:301-305.
33. Goodacre L., Goodacre J. Factors influencing the beliefs of patients with rheumatoid arthritis regarding disease-modifying medication. Rheumatology 2004, 43:583-586.
34. Kraetschmer N., Sharpe N., Urowitz S., Deber R.B. How does trust affect patient preferences for participation in decision-making. Health Expect 2004, 7:317-326.
35. Gray R., Rofail D., Allen J., Newey T. A survey of patient satisfaction with and subjective experiences of treatment with antipsychotic medication. J Adv Nurs 2005, 52:31-37.
36. Connelly J.E., Campbell C. Patients who refuse treatment in medical offices. Arch Intern Med 1987, 147:1829.
37. Bartholomew L., Parcel G., Kok G., Gottlieb N.H. Intervention mapping. Designing theoryandevidence-based health promotion programs 2001, Mayfield, Mountain View, CA.
38. Bartholomew L.K., Parcel G.S., Kok G. Intervention mapping: a process for developing theory and evidence-based health education programs. Health Educ Behav 1998, 25:545-563.
39. Van der Elst K., Meyfroidt S., De Groef A., Binnard E., De Cock D., Moons P., et al. Unravelling Preferred Outcomes of Disease and Treatment in Patients with Early Rheumatoid Arthritis: a Longitudinal Qualitative Interview Study. Ann Rheum Dis 2014, 73:112.